Ignite Creation Date:
2024-05-05 @ 5:09 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00398645
Status:
COMPLETED
Last Update Posted:
2018-01-23
First Post:
2006-11-09
Brief Title:
A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Persistent Asthma
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Study Overview
Official Title:
A Randomized Double-Blind Placebo-Controlled Parallel Group Multicenter Study to Evaluate the Efficacy and Safety of GW685698X 200 mcg Twice Daily GW685698X 200 mcg and 400 mcg Once Daily in the Morning and GW685698X 200 mcg and 400 mcg Once Daily in the Evening Compared With Placebo for 8 Weeks in Adolescent and Adult Subjects 12 Years of Age and Older With Persistent Asthma
Status:
COMPLETED
Status Verified Date:
2018-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is designed to determine if the investigational drug is effective and safe in individuals with asthma
Detailed Description:
A Randomized Double-Blind Placebo-Controlled Parallel Group Multicenter Study to Evaluate the Efficacy and Safety of GW685698X 200mcg Twice Daily GW685698X 200mcg and 400mcg Once Daily in the Morning and GW685698X 200mcg and 400mcg Once Daily in the Evening Compared with Placebo for 8 Weeks in Adolescent and Adult Subjects 12 Years of Age and Older with Persistent Asthma
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None